TP53 and myelodysplastic syndrome: These patients with MDS and acute myeloid leukemia (AML) displayed unique characteristics, including early age onset, bone marrow dysplasia, low-intermediate blast cell counts, TP53 mutations, and complex karyotypes (del5q and del7q).